135 related articles for article (PubMed ID: 19428564)
1. Specific cathepsin B inhibitor is cell-permeable and activates presentation of TTC in primary human dendritic cells.
Reich M; Wieczerzak E; Jankowska E; Palesch D; Boehm BO; Burster T
Immunol Lett; 2009 Apr; 123(2):155-9. PubMed ID: 19428564
[TBL] [Abstract][Full Text] [Related]
2. Application of specific cell permeable cathepsin G inhibitors resulted in reduced antigen processing in primary dendritic cells.
Reich M; Lesner A; Legowska A; Sieńczyk M; Oleksyszyn J; Boehm BO; Burster T
Mol Immunol; 2009 Sep; 46(15):2994-9. PubMed ID: 19615749
[TBL] [Abstract][Full Text] [Related]
3. Cathepsin E regulates the presentation of tetanus toxin C-fragment in PMA activated primary human B cells.
Burster T; Reich M; Zaidi N; Voelter W; Boehm BO; Kalbacher H
Biochem Biophys Res Commun; 2008 Dec; 377(4):1299-303. PubMed ID: 18996084
[TBL] [Abstract][Full Text] [Related]
4. An enormously active and selective azapeptide inhibitor of cathepsin B.
Wieczerzak E; Rodziewicz-Motowidło S; Jankowska E; Giełdoń A; Ciarkowski J
J Pept Sci; 2007 Aug; 13(8):536-43. PubMed ID: 17617796
[TBL] [Abstract][Full Text] [Related]
5. Modulation of antigen processing and presentation by covalently linked complement C3b fragment.
Jacquier-Sarlin MR; Gabert FM; Villiers MB; Colomb MG
Immunology; 1995 Jan; 84(1):164-70. PubMed ID: 7890301
[TBL] [Abstract][Full Text] [Related]
6. The endo/lysosomal protease cathepsin B is able to process conalbumin fragments for presentation to T cells.
Gradehandt G; Ruede E
Immunology; 1991 Nov; 74(3):393-8. PubMed ID: 1769688
[TBL] [Abstract][Full Text] [Related]
7. Bm-CPI-2, a cystatin homolog secreted by the filarial parasite Brugia malayi, inhibits class II MHC-restricted antigen processing.
Manoury B; Gregory WF; Maizels RM; Watts C
Curr Biol; 2001 Mar; 11(6):447-51. PubMed ID: 11301256
[TBL] [Abstract][Full Text] [Related]
8. Novel cell-permeable acyloxymethylketone inhibitors of asparaginyl endopeptidase.
Loak K; Li DN; Manoury B; Billson J; Morton F; Hewitt E; Watts C
Biol Chem; 2003 Aug; 384(8):1239-46. PubMed ID: 12974392
[TBL] [Abstract][Full Text] [Related]
9. An asparaginyl endopeptidase processes a microbial antigen for class II MHC presentation.
Manoury B; Hewitt EW; Morrice N; Dando PM; Barrett AJ; Watts C
Nature; 1998 Dec; 396(6712):695-9. PubMed ID: 9872320
[TBL] [Abstract][Full Text] [Related]
10. Epoxysuccinyl peptide-derived cathepsin B inhibitors: modulating membrane permeability by conjugation with the C-terminal heptapeptide segment of penetratin.
Schaschke N; Deluca D; Assfalg-Machleidt I; Höhneke C; Sommerhoff CP; Machleidt W
Biol Chem; 2002 May; 383(5):849-52. PubMed ID: 12108551
[TBL] [Abstract][Full Text] [Related]
11. Natural processing sites for human cathepsin E and cathepsin D in tetanus toxin: implications for T cell epitope generation.
Hewitt EW; Treumann A; Morrice N; Tatnell PJ; Kay J; Watts C
J Immunol; 1997 Nov; 159(10):4693-9. PubMed ID: 9366392
[TBL] [Abstract][Full Text] [Related]
12. Novel peptidyl alpha-keto amide inhibitors of calpains and other cysteine proteases.
Li Z; Ortega-Vilain AC; Patil GS; Chu DL; Foreman JE; Eveleth DD; Powers JC
J Med Chem; 1996 Sep; 39(20):4089-98. PubMed ID: 8831774
[TBL] [Abstract][Full Text] [Related]
13. Both cathepsin B and cathepsin D are necessary for processing of ovalbumin as well as for degradation of class II MHC invariant chain.
Mizuochi T; Yee ST; Kasai M; Kakiuchi T; Muno D; Kominami E
Immunol Lett; 1994 Dec; 43(3):189-93. PubMed ID: 7721331
[TBL] [Abstract][Full Text] [Related]
14. Glutathione depletion reveals impairment of antigen processing and inhibition of cathepsin activity by nitric oxide in antigen-presenting cells.
Lemaire G; Guittet O; Vesin MF; Lepoivre M; Cottet MH
Mol Immunol; 2009 Mar; 46(6):1100-8. PubMed ID: 19095306
[TBL] [Abstract][Full Text] [Related]
15. Identification of a potent and selective noncovalent cathepsin S inhibitor.
Thurmond RL; Sun S; Sehon CA; Baker SM; Cai H; Gu Y; Jiang W; Riley JP; Williams KN; Edwards JP; Karlsson L
J Pharmacol Exp Ther; 2004 Jan; 308(1):268-76. PubMed ID: 14566006
[TBL] [Abstract][Full Text] [Related]
16. Cytokines regulate proteolysis in major histocompatibility complex class II-dependent antigen presentation by dendritic cells.
Fiebiger E; Meraner P; Weber E; Fang IF; Stingl G; Ploegh H; Maurer D
J Exp Med; 2001 Apr; 193(8):881-92. PubMed ID: 11304549
[TBL] [Abstract][Full Text] [Related]
17. Simvastatin inhibits the MHC class II pathway of antigen presentation by impairing Ras superfamily GTPases.
Ghittoni R; Napolitani G; Benati D; Ulivieri C; Patrussi L; Laghi Pasini F; Lanzavecchia A; Baldari CT
Eur J Immunol; 2006 Nov; 36(11):2885-93. PubMed ID: 17048274
[TBL] [Abstract][Full Text] [Related]
18. Peptides containing acylated C-terminal gem diamines: novel irreversible inactivators of the cysteine and serine proteinases.
Gilmore BF; Lynas JF; Harriott P; Healy A; Walker B
Chem Biol Drug Des; 2006 May; 67(5):364-9. PubMed ID: 16784461
[TBL] [Abstract][Full Text] [Related]
19. Cathepsin G is differentially expressed in primary human antigen-presenting cells.
Stoeckle C; Sommandas V; Adamopoulou E; Belisle K; Schiekofer S; Melms A; Weber E; Driessen C; Boehm BO; Tolosa E; Burster T
Cell Immunol; 2009; 255(1-2):41-5. PubMed ID: 19036358
[TBL] [Abstract][Full Text] [Related]
20. Azapeptides structurally based upon inhibitory sites of cystatins as potent and selective inhibitors of cysteine proteases.
Wieczerzak E; Drabik P; Łankiewicz L; Ołdziej S; Grzonka Z; Abrahamson M; Grubb A; Brömme D
J Med Chem; 2002 Sep; 45(19):4202-11. PubMed ID: 12213061
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
